While reporting financial results for the first quarter, Thermo Fisher Scientific Inc. (TMO) on Wednesday raised its adjusted earnings and revenue guidance for the full year 2019 to reflect strong operational performance and the acquisition of Brammer Bio, partially offset by a more adverse foreign exchange environment.
from RTT - Earnings http://bit.ly/2USVFnL
via IFTTT
No comments:
Post a Comment